Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124


20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.


Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, Forbes JF; IBIS-I Investigators.

Lancet Oncol. 2015 Jan;16(1):67-75. doi: 10.1016/S1470-2045(14)71171-4. Epub 2014 Dec 11.


Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.


The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.

Korhonen T, Kuukasjärvi T, Huhtala H, Alarmo EL, Holli K, Kallioniemi A, Pylkkänen L.

Breast. 2013 Dec;22(6):1119-24. doi: 10.1016/j.breast.2013.06.001. Epub 2013 Jul 14.


Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients.

Hakala T, Kellokumpu-Lehtinen P, Kholová I, Holli K, Huhtala H, Sand J.

Scand J Surg. 2012;101(4):301-6.


Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development.

Alarmo EL, Huhtala H, Korhonen T, Pylkkänen L, Holli K, Kuukasjärvi T, Parkkila S, Kallioniemi A.

Mod Pathol. 2013 Jan;26(1):10-21. doi: 10.1038/modpathol.2012.128. Epub 2012 Aug 17.


A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial.

Palva T, Ranta H, Koivisto AM, Pylkkänen L, Cuzick J, Holli K.

Eur J Cancer. 2013 Jan;49(1):45-51. doi: 10.1016/j.ejca.2012.06.015. Epub 2012 Jul 23.


Effect of surgeon's caseload on the quality of surgery and breast cancer recurrence.

Peltoniemi P, Huhtala H, Holli K, Pylkkänen L.

Breast. 2012 Aug;21(4):539-43. doi: 10.1016/j.breast.2012.04.007. Epub 2012 May 16.


Evaluation of frequency of clinical symptoms and signs within six months prior to death in patients with advanced solid cancers.

Kaleva-Kerola J, Huhtala H, Helminen M, Pylkkänen L, Holli K.

J Palliat Care. 2012 Spring;28(1):13-20.


Long-term prognosis of breast cancer detected by mammography screening or other methods.

Lehtimäki T, Lundin M, Linder N, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Isola J, Joensuu H, Lundin J.

Breast Cancer Res. 2011;13(6):R134. doi: 10.1186/bcr3080. Epub 2011 Dec 28.


Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.


Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkilä P, Joensuu H.

Breast Cancer Res. 2011 Sep 13;13(5):R87. doi: 10.1186/bcr2944.


Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.


Parkinson's disease: interhemispheric textural differences in MR images.

Sikiö M, Holli KK, Harrison LC, Ruottinen H, Rossi M, Helminen MT, Ryymin P, Paalavuo R, Soimakallio S, Eskola HJ, Elovaara I, Dastidar P.

Acad Radiol. 2011 Oct;18(10):1217-24. doi: 10.1016/j.acra.2011.06.007. Epub 2011 Jul 23.


RAD51C is a susceptibility gene for ovarian cancer.

Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomäki K, Bützow R, Nevanlinna H.

Hum Mol Genet. 2011 Aug 15;20(16):3278-88. doi: 10.1093/hmg/ddr229. Epub 2011 May 25.


Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.

Konsti J, Lundin M, Joensuu H, Lehtimäki T, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Sailas L, Isola J, Lundin J.

BMC Clin Pathol. 2011 Jan 25;11:3. doi: 10.1186/1472-6890-11-3.


The effect of hospital volume on the outcome of breast cancer surgery.

Peltoniemi P, Peltola M, Hakulinen T, Häkkinen U, Pylkkänen L, Holli K.

Ann Surg Oncol. 2011 Jun;18(6):1684-90. doi: 10.1245/s10434-010-1514-1. Epub 2011 Jan 5.


Cervical cancer assessment in Romania under EUROCHIP-2.

Apostol I, Baban A, Nicula F, Suteu O, Coza D, Amati C, Baili P; EUROCHIP Working Group.

Tumori. 2010 Jul-Aug;96(4):545-52.


Cervical cancer screening in Bulgaria--past and present experience.

Valerianova Z, Panayotova Y, Amati C, Baili P; EUROCHIP Working Group.

Tumori. 2010 Jul-Aug;96(4):538-44.


Past, present and future of the cervical cancer screening in Latvia.

Viberga I, Engele L, Baili P; EUROCHIP Working Group.

Tumori. 2010 Jul-Aug;96(4):529-37.


Supplemental Content

Loading ...
Support Center